Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Myopia > Early refractive signs may predict faster myopic progression in children
  • Myopia

Early refractive signs may predict faster myopic progression in children

Ophthalmology 360

Children with a baseline spherical equivalent (SE) below +1.0 diopter are at increased risk for faster myopic progression, according to a study.

Researchers analyzed STORM (Shanghai Time Outside to Reduce Myopia) trial data from 4,420 children aged 6 to 9 years who were not myopic at baseline. Over a 1-year period, children with baseline SE above +1.0 D showed relatively stable refractive changes. However, those with SE below +1.0 D experienced faster progression toward myopia. This turning point was consistent across age groups and confirmed through multiple statistical methods, including restricted cubic spline modeling and segmented regression.

The researchers suggested that these findings may help clinicians identify children at higher risk for developing myopia earlier and guide timely preventive interventions.

Reference
Chen J, Qi Z, Zhang X, et al. Myopic shift accelerates at refractive diopter below +1.0 in children aged 6 to 9 years old. Am J Ophthalmol. 2025;S0002-9394(25)00369-1. doi: 10.1016/j.ajo.2025.07.015. Epub ahead of print. PMID: 40692038.

Share

Related Content

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Conference Roundup

EVO ICL surgery now FDA-approved for older patients

  • Myopia

Efficacy of low-dose atropine for myopia varies by ethnicity, analysis finds

  • Myopia

Low-dose atropine shows greatest benefit in younger children with progressive myopia in Phase 3 STAR trial

  • Myopia

Survey examines patient knowledge, attitudes, and practices related to refractive surgery

  • Glaucoma

Managing glaucoma in highly myopic eyes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon